生物資訊服務市場規模、佔有率、成長分析、按類型、按應用、按行業、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年，生物資訊服務的全球市場規模為28億美元，從2023年的32.5億美元成長到2031年的105.7億美元，在預測期間（2024-2031年）預計複合年成長率為15.9% 。

在個人化醫療需求不斷成長、基因組學和蛋白​​質組學進步以及生命科學中對高效資料管理的日益重視的推動下，全球生物資訊服務市場正在經歷強勁成長。由次世代定序技術驅動的基因組資料的激增需要生物資訊服務來進行有效的解釋和管理。人工智慧 (AI) 和機器學習 (ML) 的整合正在推動創新，特別是在預測建模和精準醫療領域。此外，採用雲端運算進行資料儲存和分析，提高了業務效率。在政府支持措施的支持下，新興國家也為市場擴張做出貢獻。到 2024 年，加強 ICT 基礎設施和第三方資訊服務提供者預計將進一步刺激這個充滿活力的產業的研究和開發。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

生物資訊服務市場規模：按類型

• 市場概況
• 定序服務
• 資料分析
• 藥物發現服務
• 基因表現分析
• 資料庫和管理服務
• 其他生物資訊服務

生物資訊服務市場規模：依應用分類

• 市場概況
• 基因組學
  • 功能基因體學
  • 結構基因體學
  • 比較基因組科學
• 化學資訊學與藥物設計
• 蛋白質體學
  • 蛋白質鑑定
  • 蛋白質結構預測
• 轉錄組學
• 代謝體學
• 其他

生物資訊服務市場規模：依產業分類

• 市場概況
• 醫療保健
  • 臨床診斷
  • 藥物發現與開發
• 動物
  • 獸醫診斷
  • 畜牧業
• 農業
  • 作物改良
  • 害蟲防治
• 學術的
  • 研究計劃
  • 教育計劃

生物資訊服務市場規模：依最終用戶分類

• 市場概況
• 學術機構與研究中心
• 醫院/診所
• 製藥和生物技術公司
• 藥品委外研發機構
• 其他

生物資訊服務市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Illumina, Inc.（USA）
• QIAGEN（Germany）
• Thermo Fisher Scientific Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• BGI Group（China）
• IBM Life Sciences（USA）
• Waters Corporation（USA）
• Partek Incorporated（USA）
• Biomatters Ltd.（New Zealand）
• Macrogen, Inc.（South Korea）
• DNASTAR, Inc.（USA）
• GenoSpace（USA）
• Nonlinear Dynamics Ltd.（UK）
• Molecular Connections Pvt. Ltd.（India）
• Eagle Genomics Ltd.（UK）
• SOPHiA GENETICS（Switzerland）
• Seven Bridges Genomics（USA）
• InSilixa Inc.（USA）

結論和建議

Global Bioinformatics Services Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.25 billion in 2023 to USD 10.57 billion by 2031, growing at a CAGR of 15.9% during the forecast period (2024-2031).

The global bioinformatics services market is experiencing robust growth, fueled by the rising demand for personalized medicine, advancements in genomics and proteomics, and an increasing emphasis on efficient data management in life sciences. The surge in genomic data from next-generation sequencing technologies necessitates bioinformatics services for effective interpretation and management. The integration of artificial intelligence (AI) and machine learning (ML) is driving innovation, particularly in predictive modeling and precision medicine. Moreover, the adoption of cloud computing for data storage and analysis enhances operational efficiency. Emerging economies are also contributing to market expansion, aided by supportive government initiatives. Enhanced ICT infrastructure and third-party data service providers are expected to further stimulate research and development in this dynamic sector through 2024.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Services Market Segmental Analysis

Global Bioinformatics Services Market is segmented by type, application, sector, end user and region. Based on type, the market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services and other bioinformatics services. Based on application, the market is segmented into genomics, cheminformatics & drug design, proteomics, transcriptomics, metabolomics and others. Based on sector, the market is segmented into medical, animal, agricultural and academics. Based on end user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, CROs and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioinformatics Services Market

The global bioinformatics services market is significantly driven by advancements in genomics and proteomics research, particularly due to the increasing focus on personalized medicine. This approach seeks to offer customized healthcare solutions that are aligned with an individual's genetic profile and specific characteristics. Bioinformatics services are essential for the analysis and interpretation of genomic data, enabling the identification of biomarkers, assessment of disease risk, and optimization of treatment strategies. Consequently, the growing demand for personalized medicine is fostering the widespread adoption of bioinformatics services in various research and clinical environments, further propelling market growth.

Restraints in the Global Bioinformatics Services Market

The Global Bioinformatics Services market faces significant restraints due to the inherent complexity and quality of biological data. These services depend on large volumes of genomic and proteomic information, but the diversity and intricacy of this data present challenges related to standardization and integration, as well as quality assurance. Issues such as incomplete or inconsistent datasets can result in inaccurate outcomes, ultimately obstructing the proper interpretation of biological processes. Consequently, these limitations can diminish the overall efficiency and effectiveness of bioinformatics services, making it difficult for stakeholders to rely on the insights generated from such analyses.

Market Trends of the Global Bioinformatics Services Market

The Global Bioinformatics Services market is experiencing a significant trend towards the adoption of cloud computing solutions, which are revolutionizing how researchers manage and analyze biological data. This shift is driven by the demand for scalability, cost-effectiveness, and enhanced collaboration, allowing researchers to overcome traditional limitations of on-premises infrastructure. Cloud-based services facilitate seamless data storage and analysis while offering improved accessibility for teams working across geographical boundaries. As institutions increasingly recognize the benefits of cloud technology, the market for bioinformatics services is poised for robust growth, with investment in cloud platforms expected to surge, shaping the future landscape of bioinformatics innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Bioinformatics Services Market Size by Type & CAGR (2024-2031)

• Market Overview
• Sequencing Services
• Data Analysis
• Drug Discovery Services
• Differential Gene Expression Analysis
• Database and Management Services
• Other Bioinformatics Services

Global Bioinformatics Services Market Size by Application & CAGR (2024-2031)

• Market Overview
• Genomics
  • Functional Genomics
  • Structural Genomics
  • Comparative Genomics
• Cheminformatics & Drug Design
• Proteomics
  • Protein Identification
  • Protein Structure Prediction
• Transcriptomics
• Metabolomics
• Others

Global Bioinformatics Services Market Size by Sector & CAGR (2024-2031)

• Market Overview
• Medical
  • Clinical Diagnostics
  • Drug Discovery & Development
• Animal
  • Veterinary Diagnostics
  • Animal Breeding
• Agricultural
  • Crop Improvement
  • Pest Control
• Academics
  • Research Projects
  • Educational Programs

Global Bioinformatics Services Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic Institutes & Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Cros
• Other

Global Bioinformatics Services Market Size & CAGR (2024-2031)

• North America (Type, Application, Sector, End User)
  • USA
  • Canada
• Europe (Type, Application, Sector, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Sector, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Sector, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Sector, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomatters Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenoSpace (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonlinear Dynamics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Connections Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eagle Genomics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOPHiA GENETICS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSilixa Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations